NeuroSense Therapeutics Ltd.
NRSN · XNASCIK 1875091fmd_1CWEBJ6G4S568N65AE5ZKTFTF6Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2019 to Dec 31, 2025, 12 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Research and development | – | – | 1 | 6 | 7 | 6 | 6 |
| Operating income | (1) | (3) | (3) | (11) | (12) | (10) | (11) |
| Interest expense | 0 | 0 | 1 | 0 | 2 | – | – |
| Other non-operating income (expense) | – | – | (0) | 0 | 2 | (0) | (0) |
| Net income | (1) | (3) | (3) | (10) | (10) | (10) | (11) |